Comment
doi: 10.1158/2159-8290.CD-NB2015-050.
Epub 2015 Apr 16.
CTCs Could Shorten Drug Trials
- PMID: 25883015
- DOI: 10.1158/2159-8290.CD-NB2015-050
Item in Clipboard
Comment
CTCs Could Shorten Drug Trials
Cancer Discov.
2015 Jun.
Abstract
In a phase III study, circulating tumor cells and blood levels of the enzyme lactate dehydrogenase predicted survival in patients with metastatic prostate cancer. Use of these biomarkers as surrogate predictors of survival could speed clinical trials of experimental therapies for prostate cancer.
©2015 American Association for Cancer Research.
Comment on
-
Circulating tumor cell biomarker panel as an individual-level surrogate for survival in metastatic castration-resistant prostate cancer.J Clin Oncol. 2015 Apr 20;33(12):1348-55. doi: 10.1200/JCO.2014.55.3487. Epub 2015 Mar 23. J Clin Oncol. 2015. PMID: 25800753 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
